2019

1. Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial

   Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1599-1609.e1